GlassScriptPhysician profile
Rafael Rivera Rivera
NPI 1669432209
$16,273.32
in general payments reported to CMS, 2019-2025
44 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $1,403 · 2021: $1,857 · 2022: $2,404 · 2023: $2,676 · 2024: $3,079 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,162 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,161.94 |
| Education | $171.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,237.56 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,593.40 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Mylan Specialty L.P. | $1,528.63 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,037.50 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $959.11 | 2019-2025 | Dupixent |
| Genzyme Corporation | $752.24 | 2019-2025 | |
| Philips North America LLC | $614.22 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $595.76 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $546.77 | 2022-2025 | Tezspire |
| United Therapeutics Corporation | $448.61 | 2020-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $407.37 | 2019-2025 | Winrevair, Keytruda |
| Novartis Pharmaceuticals Corporation | $322.71 | 2019-2025 | |
| Noah Medical Corporation | $303.24 | 2024 | Galaxy |
| Pfizer INC. | $296.02 | 2019-2025 | |
| Baxter Healthcare | $283.38 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $279.53 | 2019-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $267.86 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $222.87 | 2022-2025 | Glassia |
| Abiomed | $199.65 | 2023-2024 | Impella |
| Janssen Pharmaceuticals, INC | $163.84 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $153.89 | 2019 | |
| Insmed, INC. | $138.17 | 2019-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $118.05 | 2019-2021 | |
| Allergan, INC. | $101.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $82.32 | 2019 | |
| Verona Pharma, INC. | $75.98 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $69.74 | 2022-2023 | Purified Cortrophin Gel |
| Electromed, INC. | $64.55 | 2021-2025 | Smartvest |
| Mallinckrodt Hospital Products INC. | $53.54 | 2022-2023 | Acthar |
| Sanofi-Aventis U.S. LLC | $52.80 | 2020-2021 | |
| Inspire Medical Systems, INC. | $40.57 | 2023-2024 | Inspire |
| Chiesi USA, INC. | $36.07 | 2020-2022 | |
| Inari Medical, INC. | $28.15 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mallinckrodt Enterprises LLC | $22.69 | 2019 | |
| 3b Medical, INC. | $22.17 | 2025 | Luna |
| Advanced Respiratory, INC | $21.73 | 2021 | |
| Tactile Systems Technology INC | $21.15 | 2022 | |
| Penumbra, INC. | $19.37 | 2023 | Indigo System |
| Lilly USA, LLC | $17.90 | 2025 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $16.52 | 2021 | |
| Circassia INC. | $16.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.32 | 2024 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $12.30 | 2021 | |
| Nabriva Therapeutics, Plc | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Rivera Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.